Exercise training in cancer related cardiomyopathy

The development of new medical therapies in oncology over the past decades is an impressive success and has fundamentally changed the outcome of cancer patients. Improved diagnostic algorithms and an increasing arsenal of modern and novel therapies allowed achieving higher rates of remission and cancer-free survival for many malignancies. As a result, a significant improvement in survival rates is evident and the medical community is confronted with a larger number of patients who have a history of oncological treatment and are at risk for related cardiac complications (1). If expressed in numbers, one can see an increase in the overall 5-year survival rates for all cancers in the United States that rose from around 50% in the late seventies to 69% in the past decade (1)